Encelto, the first FDA-approved treatment for MacTel, is implanted intravitreally during a surgery performed by a qualified ophthalmologist. The Food and Drug Administration (FDA) has approved ...

The first treatment for macular telangiectasia type 2 is set to enter the market following U.S. FDA approval of NT-501 (revakinagene taroretcel) from Neurotech Pharmaceuticals Inc., a privately held ...

Common symptoms include facial redness, a rash, acne-like bumps, and visible blood vessels (telangiectasia ... and redness; this treatment is gentler than laser therapy. Laser therapy uses ...

Dual cool laser effectively treats spider ... for reticular veins rather than spider veins (telangiectasias). Sclerotherapy for the treatment of reticular veins. Photo courtesy of Dr. Vein Dr ...

for the treatment of Macular Telangiectasia type 2 (MacTel). MacTel is a neurodegenerative disease of the retina in adults that causes progressive and irreversible vision loss, significantly ...

is the first therapy to be approved for macular telangiectasia type 2. The FDA approved revakinagene taroretcel-lwey (Encelto; Neurotech Pharmaceuticals) for the treatment of macular ...